Allogene Therapeutics ALLO Property, plant and equipment at cost
Property, plant and equipment at cost at other companies
Other financials
Where this comes from
Reported directly by Allogene Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.
The official record: Allogene Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Allogene Therapeutics's property, plant and equipment at cost.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Allogene Therapeutics's property, plant and equipment at cost?
- Allogene Therapeutics (ALLO) reported property, plant and equipment at cost of $145.43M in Q1 2026.
- How has Allogene Therapeutics's property, plant and equipment at cost changed year-over-year?
- Allogene Therapeutics's property, plant and equipment at cost decreased by 2.2% year-over-year, from $148.63M to $145.43M.
- What is the long-term trend for Allogene Therapeutics's property, plant and equipment at cost?
- Over 5 years (2020 to 2025), Allogene Therapeutics's property, plant and equipment at cost has grown at a 2.0% compound annual growth rate (CAGR), from $131.75M to $145.37M.